| 000 | 01193 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517192843.0 | ||
| 264 | 0 | _c20200331 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1536-5166 | ||
| 024 | 7 |
_a10.1097/WNO.0000000000000609 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aForoozan, Rod | |
| 245 | 0 | 0 |
_aVigabatrin: Lessons Learned From the United States Experience. _h[electronic resource] |
| 260 |
_bJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society _c12 2018 |
||
| 300 |
_a442-450 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aGABA Agents _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRetinal Pigment Epithelium _xpathology |
| 650 | 0 | 4 |
_aScotoma _xdiagnosis |
| 650 | 0 | 4 | _aTomography, Optical Coherence |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 |
_aVigabatrin _xtherapeutic use |
| 650 | 0 | 4 |
_aVisual Fields _xphysiology |
| 773 | 0 |
_tJournal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society _gvol. 38 _gno. 4 _gp. 442-450 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNO.0000000000000609 _zAvailable from publisher's website |
| 999 |
_c27928047 _d27928047 |
||